"10.1371_journal.pone.0060127","plos one","2013-04-16T00:00:00Z","Nathanael Lapidus; Xavier de Lamballerie; Nicolas Salez; Michel Setbon; Rosemary M Delabre; Pascal Ferrari; Nanikaly Moyen; Marie-Lise Gougeon; Frédéric Vely; Marianne Leruez-Ville; Laurent Andreoletti; Simon Cauchemez; Pierre-Yves Boëlle; Éric Vivier; Laurent Abel; Michaël Schwarzinger; Michèle Legeas; Pierre Le Cann; Antoine Flahault; Fabrice Carrat","Institut National de la Santé et de la Recherche Médicale, UMR-S 707, Paris, France; Université Pierre et Marie Curie-Paris 6, UMR-S 707, Paris, France; Unité des Virus Emergents, UMR-D 190, Aix-Marseille université and Institut de Recherche pour le Développement, Marseille, France; Laboratoire de Virologie, Pôle hospitalier de Microbiologie et Maladies Infectieuses, Assistance Publique, Hôpitaux de Marseille, France; Ecole des Hautes Etudes en Sante Publique, Rennes, France; Institut Pasteur, Antiviral Immunity, Biotherapy and Vaccine Unit, Paris, France; Centre d'Immunologie de Marseille-Luminy (CIML), Université de la Méditerranée UM 631, Campus de Luminy, Marseille, France; Institut National de la Santé et de la Recherche Médicale, UMR-S 631, Marseille, France; CNRS, UMR6102, Marseille, France; Assistance Publique, Hôpitaux de Marseille, Hôpital de la Conception, Marseille, France; Université Paris Descartes, Sorbonne Paris Cité, EA 36-20, Paris, France; Laboratoire de Virologie, Hôpital Necker, AP-HP, Paris, France; Unité de Virologie Médicale et Moléculaire, Centre Hospitalier Universitaire, Reims, France; IFR 53/EA-4303 (DAT/PPCIDH), Faculté de Médecine, Reims, France; Medical Research Council Centre for Outbreak Analysis and Modeling, Department of Infectious Disease Epidemiology, Imperial College, London, United Kingdom; Assistance Publique-Hôpitaux de Paris, Hôpital Saint Antoine, Unité de Santé Publique, Paris, France; Laboratoire de Génétique Humaine des Maladies Infectieuses, Institut National de la Santé et de la Recherche Médicale, U 550, Paris, France; Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, New York, United States of America; Université Paris-Diderot, Sorbonne Paris Cité, UMR 738, Paris, France; Équipe ATIP/AVENIR, Inserm, UMR 738, Paris, France","Critical revision of manuscript: NL XdL NS M. Setbon RMD PF NM MLG FV MLV L. Andreoletti SC PYB EV L. Abel M. Schwarzinger ML PLC AF FC. Participated in the acquisition of data: NL PF M. Setbon RMD FC. Performed seriological analyses: XdL NS NM. Drafted the protocol: NL FC AF. Contributed to the conception of the study: NL XdL NS M. Setbon RMD PF NM MLG FV MLV L. Andreoletti SC PYB EV L. Abel M. Schwarzinger ML PLC AF FC. Performed the experiments: NL PF M. Setbon RMD FC XdL NS NM. Analyzed the data: NL FC. Wrote the paper: NL FC.","Pr Carrat reported not having shares or paid employment with pharmaceutical companies; received honoraria from Novartis, GlaxoSmithKline and Boiron and received travel support to attend scientific meetings from Novartis. Other authors have no competing interest to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","04","Nathanael Lapidus","NL",20,FALSE,NA,3,2,2,TRUE,TRUE,TRUE,8,"2;9;11;12;13;14;15;18",TRUE
